Open AccessEffect of Different Doses of Dexmedetomidine as Adjuvant in Bupivacaine -Induced Subarachnoid Block for Traumatized Lower Limb Orthopaedic Surgery: A Prospective, Double-Blinded and Randomized Controlled Study
Author(s) -
Susanta Halder,
Anjan Das,
Debasmita Mandal,
Mainak Chandra,
Sajal Ray,
Madhuri Ranjana Biswas,
Parthojit Mandal,
Tanuka Das
Publication year - 2014
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2014/9670.5118
Subject(s) - dexmedetomidine , medicine , anesthesia , bupivacaine , analgesic , saline , hemodynamics , randomized controlled trial , surgery , sedation
Improved pain management for blunt trauma to the lower extremity has shown to reduce morbidity, induce early ambulation and improve long-term outcomes. Dexmedetomidine; a selective α-2 agonist; has recently been used intrathecally in different doses to prolong spinal anaesthesia. We evaluated the effect of adding two different doses of dexmedetomidine to hyperbaric bupivacaine for spinal anaesthesia. The primary endpoints were the onset and duration of sensory, motor block and duration of analgesia.